Biotest Pharmaceuticals Corporation News

For more information about news releases and recent announcements, please contact media@biotestpharma.com

02/ 4/2013	Biotest Pharmaceuticals Announces First Commercial Sales of BIVIGAM™
01/31/2013	BIVIGAM™ [Immune Globulin Intravenous (Human), 10% Liquid] is the First New IVIG Product Approved with a Validated and FDA Approved Thrombin Generation Assay (TGA) Test
01/10/2013	Biotest Pharmaceuticals Announces Strategic Long-Term Manufacturing, Supply and License Agreement
12/20/2012	FDA Approves Biotest’s BIVIGAM™, an Intravenous Immune Globulin (Human), 10% liquid
04/11/2012	Biotest announces clinical trial data for its new investigational Intravenous Immunoglobulin (IVIG) product for the US market
03/ 8/2012	Biotest Pharmaceuticals Corporation Announces Jordan Siegel as New Chief Executive Officer
06/21/2011	Abbott and Biotest Announce Global Agreement to Development and Commercialize Novel Antibody for Autoimmune Diseases
11/ 3/2010	Biotest submits BivigamTM dossier for regulatory approval to US Food and Drug Administration

Items 1-8 of 15

Biotest Pharmaceuticals Corporation - From Nature for Life